Seleziona una pagina

TRIBUTYRIN

SILO started the production of tributyrin in 2004.
The Tributyrin produced by SILO is characterized by a high level of purity and a high amount of triglycerides of butyric acid (>90%).

MAIN BENEFITS

  • ETriglycerides of butyric acid do not need any protection since they are not absorbed in the crop and gizzard (their behavior is similar to that of lipids)
  • ELipases easily separate the butyric acid from the glycerol due to the low melting point (-4°C) making butyric acid available in the gut
  • ETributyrin is a very efficient way to deliver the butyric acid to the gut: beneficial effects on gut integrity and on FCR are among the main effects appreciated by our clients. An example of beneficial effects on FCR is reported here below:

CHARACTERISTIC

  • EAvailable in dry and liquid form
  • ENon corrosive; odorless; highly palatable
  • EHeat stable up to 150°C
  • EpH stable (from pH 1 to pH 8)
  • EStable during pelletizing/extrusion
  • ECompatible with feed or premix ingredients: plant extracts, vitamins, proteins, enzymes etc.
  • EReduced in GMP+/QS/FamiQS & ISO certified facilities
  • EPackaging: 25 kg bags, 750 kg big bag, 20 kg cans, 1000 kg IBC

Pen Trial with broilers aimed at assessing the effects of Tributyrin produced by Silo on FCR

Location: Poulpharm (Belgium)
Animals: Ross 308 one-day-old chicks (male)
Replications: 12 pen/replicates/treatment, *18 birds/pen
Trial duration: 42 days
Basa diet: corn- wheat- soybean meal based pelletized diets (w/ Natuphos E 750 FTU / kg; Natugrain TS 100g / MT & **Diclazuril 0.5%)
Feeding periods: starter 0-14 days, grower 15-28 days, finisher 29-42 days
Treatments: control group: basal diet; Tributyrin group: basal diet supplemented with 500 g of Tributyrin/ton of feed
Medical Treatments:
day 0: Avinew Neo + IB primer, administered via spray on birds
day 13: Hipraviar + Hipragumboro G97, administered via drinking water
day 20: IB QX + Hipragumboro G97, administered via drinking water

FCR from day 0 to day 42

Significant differences between control and dietary treatments are indicated with (*) (P<0.05)